ReviewCurrent opinion in colloid & interface science2021
An opinion on the multiscale nature of Covid-19 type disease spread.
Review in Current opinion in colloid & interface science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Editorial Overview: Hot Topic: COVID-19: Colloid and Interface Aspects of COVID-19.Current opinion in colloid & interface science · 2021Article
- Efficacy of homemade face masks against human coughs: Insights on penetration, atomization, and aerosolization of cough droplets.Physics of fluids (Woodbury, N.Y. : 1994) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recognizing the multiscale, interdisciplinary nature of the Covid-19 transmission dynamics, we discuss some recent developments concerning an attempt to construct a disease spread model from the flow physics of infectious droplets and aerosols and the frequency of contact between susceptible individuals with the infectious aerosol cloud. Such an approach begins with the exhalation event-specific, respiratory droplet size distribution (both airborne/aerosolized and ballistic droplets), followed by tracking its evolution in the exhaled air to estimate the probability of infection and the rate constants of the disease spread model. The basic formulations and structure of submodels, experiments involved to validate those submodels, are discussed. Finally, in the context of preventive measures, respiratory droplet-face mask interactions are described.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.